R
Remedy Pharmaceuticals
Remedy Pharmaceuticals, Inc. - Home
About Remedy Pharmaceuticals
Remedy Pharmaceuticals is dedicated to developing innovative treatments for central nervous system (CNS) diseases and injuries, with a particular focus on stroke and cerebral edema. The company operates in the biopharmaceutical industry, targeting healthcare providers and patients affected by CNS conditions. Remedy Pharmaceuticals' business model revolves around the research, development, and commercialization of its core product, Cirara, which aims to improve patient outcomes in cases of large hemispheric infarction and other severe CNS-related conditions. The company generates revenue through the sale and licensing of its pharmaceutical products.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | May 2017 | $120M | $120M | Biogen | — |
| EARLY VCEquity / VC | Jan 2017 | $3M | $12M | Undisclosed | — |
Growth signals
Latest recorded traffic for Remedy Pharmaceuticals is 710 monthly website visits, down 35.5% over the last three months. Remedy Pharmaceuticals's team declined 28.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Remedy Pharmaceuticals in the New York City ecosystem
The Remedy Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Broadview Ventures
Other known investors4 additional known investors
Biogen
University of Maryland Baltimore County
Biosciences Research and Commercialization Center
University of Maryland Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Remedy Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Remedy Pharmaceuticals’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










